The sale is small in absolute and relative terms, but the pattern of recent sales by a former officer (7,064 shares on June 4 and 45,481 shares on May 8) suggests ongoing portfolio liquidation. Monitor for additional Form 4 filings or a larger Form 144 that could signal a more significant divestment. No immediate price impact expected.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Jun 8 $32.39entry
- T+1 · 5mo ago +5.28%α +5.57% · $34.10
- T+5 · 5mo ago +5.53%α +3.41% · $34.18
- T+20 · 4mo ago +14.26%α +12.63% · $37.01
- T+60 · due 3mo ago Pending
Price Chart
How similar events traded
Executive Summary
Former officer Sandip Kapadia filed a Form 144 notice of intent to sell 2,101 shares of Harmony Biosciences (HRMY) with an estimated aggregate market value of approximately $69,504. The shares are to be sold through Morgan Stanley Smith Barney and were acquired via exercise of options under a registered plan. This is a relatively small sale relative to Kapadia's prior reported holdings and the company's $1.9B market cap, but as a former officer filing an intent to sell, it warrants monitoring.
Key Facts
- Form 144 filed by Sandip Kapadia, a former officer of Harmony Biosciences Holdings, Inc.
- Proposed sale of 2,101 shares of common stock with an estimated aggregate market value of $69,504.02.
- Shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services.
- Shares acquired via exercise of options under a registered plan on June 5, 2026.
- Kapadia previously sold 7,064 shares on June 4, 2026, and 45,481 shares on May 8, 2026.
- The filing is an advance notice of intent to sell; the sale may not be completed.
Financial Impact
Proposed sale of 2,101 shares valued at approximately $69,504, representing a small fraction of the company's $1.9B market cap.
Risk Factors
- Insider selling by a former officer may signal lack of confidence or personal liquidity needs, though the amount is small.
- The filing is an intent to sell; the actual sale may not occur, reducing the signal value.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005696 |
| Document: 0001950047-26-005696-index.html | 0001950047-26-005696 |
| Document: 0001950047-26-005696.txt | 0001950047-26-005696 |
Track record
20 reports on HRMY
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +14.82% at T+20 after the Jul 16, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $33.21 Now $32.96 −0.75% settles Dec 15
- Nov 4, 202612d ago 8-K Bearish 5/10 No price data
- Nov 4, 202612d ago Press Release Bearish 5/10 Entry $34.42 Now $32.96 +4.23% settles Dec 3
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $37.02 Now $32.96 −10.97% settles Dec 2
- Oct 30, 202617d ago 8-K/A Neutral 3/10 Entry $37.91 Now $32.96 −13.06% settles Dec 1
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $38.50 Now $32.96 −14.39% settles Nov 25
- Oct 13, 20264w ago 8-K Neutral 3/10 Entry $37.03 to $33.55 Now $32.96 −10.99% ▼ −9.40% −5.79% vs SPY
- Oct 1, 20266w ago Press Release Neutral 3/10 Entry $39.57 to $38.59 Now $32.96 −16.70% ▼ −2.48% −3.18% vs SPY
- Aug 4, 202614w ago 8-K Bullish 7/10 No price data
- Aug 4, 202614w ago Press Release Bullish 6/10 Entry $38.78 Now $32.96 −15.01% No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers